Oncology and Hematology - Global Oncology Academy

273-288 of 743

Managing PNH: Clinical Considerations
Managing PNH: Clinical Considerations
Project Oncology®
Managing PNH: Clinical Considerations
Charles Turck, PharmD, BCPS, BCCCP; Jamie Koprivnikar, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Jamie Koprivnikar, MD
- Abdulraheem Yacoub, MD
Examining Unmet Needs in Paroxysmal Nocturnal Hemoglobinuria
Examining Unmet Needs in Paroxysmal Nocturnal Hemoglobinuria
Project Oncology®
Examining Unmet Needs in Paroxysmal Nocturnal Hemoglobinuria
Brian P. McDonough, MD, FAAFP
- Brian P. McDonough, MD, FAAFP
Examining the Treatment Paradigm for Paroxysmal Nocturnal Hemoglobinuria
Examining the Treatment Paradigm for Paroxysmal Nocturnal Hemoglobinuria
Project Oncology®
Examining the Treatment Paradigm for Paroxysmal Nocturnal Hemoglobinuria
Charles Turck, PharmD, BCPS, BCCCP; Brian Mulherin, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Brian Mulherin, MD
Conquering the Burden & Impacts of PNH
Conquering the Burden & Impacts of PNH
Project Oncology®
Conquering the Burden & Impacts of PNH
Charles Turck, PharmD, BCPS, BCCCP; Hana Safah, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Hana Safah, MD
- Timothy Kubal, MD
Managing PNH Patients: Addressing the Unmet Needs
Managing PNH Patients: Addressing the Unmet Needs
Project Oncology®
Managing PNH Patients: Addressing the Unmet Needs
Charles Turck, PharmD, BCPS, BCCCP; Brian Mulherin, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Brian Mulherin, MD
Understanding the Role of the Alternate Complement Pathway in PNH
Understanding the Role of the Alternate Complement Pathway in PNH
Project Oncology®
Understanding the Role of the Alternate Complement Pathway in PNH
Jennifer Caudle, DO, FACOFP; Catherine Broome, MD
- Jennifer Caudle, DO, FACOFP
- Catherine Broome, MD
Improving PNH Patient Outcomes
Improving PNH Patient Outcomes
Project Oncology®
Improving PNH Patient Outcomes
Charles Turck, PharmD, BCPS, BCCCP; David Dingli, MD, PhD
- Charles Turck, PharmD, BCPS, BCCCP
- David Dingli, MD, PhD
Stories in PNH: Case Experiences from the Clinic
Stories in PNH: Case Experiences from the Clinic
Project Oncology®
Stories in PNH: Case Experiences from the Clinic
Charles Turck, PharmD, BCPS, BCCCP; Timothy Kubal, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Timothy Kubal, MD
Advances in Colorectal Cancer Detection: Exploring the Role of Blood-Based Tests
Advances in Colorectal Cancer Detection: Exploring the Role of Blood-Based Tests
GI Insights
Advances in Colorectal Cancer Detection: Exploring the Role of Blood-Based Tests
Peter Buch, MD, FACG, AGAF, FACP; Aasma Shaukat, MD, MPH
- Peter Buch, MD, FACG, AGAF, FACP
- Aasma Shaukat, MD, MPH
Recognizing the Burden of Paroxysmal Nocturnal Hemoglobinuria
Recognizing the Burden of Paroxysmal Nocturnal Hemoglobinuria
Project Oncology®
Recognizing the Burden of Paroxysmal Nocturnal Hemoglobinuria
Brian P. McDonough, MD, FAAFP
- Brian P. McDonough, MD, FAAFP
Next-Generation Horizons in PNH Therapies
Next-Generation Horizons in PNH Therapies
Project Oncology®
Next-Generation Horizons in PNH Therapies
Vinod Pullarkat, MD
- Vinod Pullarkat, MD
Navigating the Vascular Risks of Cancer Therapy: Balancing Cardiac Safety and Tumor Control
Navigating the Vascular Risks of Cancer Therapy: Balancing Cardiac Safety and Tumor Control
Heart Matters
Navigating the Vascular Risks of Cancer Therapy: Balancing Cardiac Safety and Tumor Control
Jun-ichi Abe
- Jun-ichi Abe
10-Year PORTEC-3 Outcomes: Chemoradiotherapy in High-Risk Endometrial Cancer
10-Year PORTEC-3 Outcomes: Chemoradiotherapy in High-Risk Endometrial Cancer
Project Oncology®
10-Year PORTEC-3 Outcomes: Chemoradiotherapy in High-Risk Endometrial Cancer
Evaluating a Lower-Intensity Treatment Regimen in AML: Phase 2 Results from PARADIGM
Evaluating a Lower-Intensity Treatment Regimen in AML: Phase 2 Results from PARADIGM
Project Oncology®
Evaluating a Lower-Intensity Treatment Regimen in AML: Phase 2 Results from PARADIGM
Ryan Quigley
- Ryan Quigley
Predicting Prognosis in DLBCL: The Role of Immune-Related Gene Signatures
Predicting Prognosis in DLBCL: The Role of Immune-Related Gene Signatures
Project Oncology®
Predicting Prognosis in DLBCL: The Role of Immune-Related Gene Signatures
Refining Risk, Reducing Burden: ENDORISK-2 and Preoperative Stratification in Endometrial Cancer
Refining Risk, Reducing Burden: ENDORISK-2 and Preoperative Stratification in Endometrial Cancer
Project Oncology®
Refining Risk, Reducing Burden: ENDORISK-2 and Preoperative Stratification in Endometrial Cancer

18/11